ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $22,451,000 | +4.8% | 379,682 | -13.8% | 0.08% | -1.2% |
| Q3 2020 | $21,423,000 | -4.5% | 440,539 | -5.0% | 0.09% | -13.1% |
| Q2 2020 | $22,426,000 | +8.5% | 463,539 | -37.7% | 0.10% | -22.0% |
| Q1 2020 | $20,661,000 | -38.1% | 743,734 | -33.3% | 0.13% | -28.2% |
| Q4 2019 | $33,373,000 | -7.3% | 1,115,411 | -4.3% | 0.18% | -27.8% |
| Q3 2019 | $36,011,000 | -36.0% | 1,165,411 | 0.0% | 0.24% | -36.0% |
| Q2 2019 | $56,289,000 | – | 1,165,411 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |